The Quick Guide to Migraine SOAP Note Example

Migraine is one of those conditions where the patient's suffering is completely invisible to an outside observer.

Your patient sits across from you in obvious distress, but their vital signs are normal, their neurological exam is normal, and there's nothing objective you can point to that proves the severity of their experience.

Yet you need to document this visit in a way that convinces an insurance company to approve a $1,200 monthly medication or an MRI that costs thousands of dollars.

This is where most migraine documentation falls short.

Providers describe the headache, maybe run through the exam, prescribe something, and move on. But insurance companies reviewing these notes for prior authorization are looking for very specific things: headache characteristics that confirm migraine diagnosis, documentation of disability and functional impact, failed trials of preventive medications, and red flags that were appropriately ruled out.

Without this documentation framework, even the best clinical care gets denied coverage.

I built SOAP Notes Doctor after watching too many providers fight with prior authorization denials for treatments their patients desperately needed, simply because the documentation didn't tell the complete story.

Let me show you what migraine notes need to include.

Why Migraine Documentation Is Uniquely Challenging

Migraine presents documentation challenges that most other conditions don't have:

The suffering is subjective and invisible. Unlike a broken bone or a rash, there's no objective finding an insurance reviewer can see that proves the patient is debilitated by their headaches.

Prior authorization is almost guaranteed for newer preventive medications (CGRP inhibitors like Aimovig, Emgality) and even some abortive treatments. You need documentation that justifies why older, cheaper medications won't work.

Red flag symptoms overlap with migraine features. Severe headache, visual changes, and nausea can indicate serious pathology. Your notes need to show you considered dangerous causes while appropriately diagnosing migraine.

Chronic vs episodic classification matters for treatment decisions and insurance coverage. You need to document frequency clearly.

Functional impact drives medical necessity. Insurance doesn't care that headaches hurt; they care whether headaches prevent work, disrupt daily life, or cause disability. Your notes must capture this.

The difference between "patient has bad headaches" and documentation that secures coverage is knowing exactly what to include.

What Insurance Companies Need to See in Migraine Notes

When reviewing migraine documentation for prior authorization, insurance medical directors are looking for specific elements:

They want confirmation that the diagnosis is actually migraine (not tension headache or medication overuse headache). This means documenting the characteristics: unilateral location, pulsating quality, moderate to severe intensity, aggravation by physical activity, plus associated symptoms like nausea or photophobia.

They want to see the frequency documented clearly: How many headache days per month? This determines chronic vs episodic classification and which treatments are appropriate.

They want evidence of functional impairment: missed work days, inability to perform daily activities, emergency department visits. This establishes medical necessity.

They want documentation of failed conservative treatments before approving expensive preventive medications. Usually this means documented trials of at least two different classes of preventive medications (like a beta-blocker and an antiepileptic) that either didn't work or caused intolerable side effects.

And critically, they want confirmation that you've ruled out secondary headache causes: no concerning features on history, appropriate neurological examination, and consideration of imaging when indicated.

Your documentation needs to address all of these elements, ideally in a format that makes it easy for reviewers to find what they're looking for.

Example 1: First-Time Migraine Diagnosis

Patient: 32-year-old female
Chief Complaint: Severe recurring headaches for 3 months
Visit: New patient evaluation

S – Subjective:

Patient reports experiencing severe headaches approximately 2-3 times monthly for past 3 months. Describes headaches as throbbing pain, usually on left side of head, occasionally right side or bilateral. Pain intensity 7-8/10 during episodes. Headaches typically develop over 30-60 minutes, last 8-12 hours if untreated. Associated with nausea (no vomiting), sensitivity to light and sound—needs to lie down in dark quiet room. Denies visual changes preceding headaches, though notes lights seem "too bright" during headache. Physical activity makes pain worse; has to miss work when severe. Takes ibuprofen 600mg with minimal relief. Denies fever, neck stiffness, confusion, or focal weakness. No head trauma history. Mother has migraine history. Menstrual cycle regular, headaches not clearly related to cycle timing though possibly worse around period. Sleep pattern generally good, 7 hours nightly. Stress level moderate (works in marketing, deadline-driven job). Caffeine intake: 2 cups coffee daily.

O – Objective:

Vital Signs: BP 118/76, HR 72, Temp 98.4°F
General: Alert, well-appearing, no acute distress today (headache-free interval)
HEENT: Normocephalic, no sinus tenderness, no temporal artery tenderness
Neurological Exam: CN II-XII intact, visual fields full, pupils equal and reactive, no papilledema on fundoscopy, motor strength 5/5 all extremities, sensation intact, DTRs 2+ symmetric, coordination normal (finger-to-nose, heel-to-shin), gait normal, Romberg negative, no meningeal signs

A – Assessment:

Migraine without aura, episodic (2-3 headache days per month). Diagnosis based on International Classification of Headache Disorders (ICHD-3) criteria: recurrent attacks lasting 4-72 hours with unilateral location, pulsating quality, moderate-to-severe intensity, aggravation by physical activity, plus nausea and photophobia/phonophobia. Family history positive for migraine. No red flag features identified: no fever, no focal neurological deficits, no papilledema, gradual onset, typical migraine characteristics. Does not meet criteria for chronic migraine (fewer than 15 headache days monthly). Neuroimaging not indicated at this time given typical presentation and normal neurological examination.

P – Plan:

Abortive Treatment: Prescribed sumatriptan 100mg tablets, take 1 tablet at migraine onset, may repeat once after 2 hours if needed (maximum 200mg per 24 hours). Instructed to take early in headache rather than waiting for severe pain. Advised not to exceed 9 days per month to avoid medication overuse headache.

Lifestyle Modifications: Discussed migraine trigger identification and avoidance. Recommended headache diary tracking: date, severity, duration, potential triggers (sleep, stress, foods, hormonal), medication use. Encouraged regular sleep schedule, consistent meal timing, adequate hydration, stress management techniques. Continue current caffeine intake at consistent level (sudden changes can trigger headaches).

Follow-up Plan: Return in 6-8 weeks to review headache diary and assess sumatriptan effectiveness. If frequency increases to greater than 4 migraines monthly or significant disability persists, will discuss preventive medication options. Provided Migraine Disability Assessment (MIDAS) questionnaire to complete for next visit.

Patient Education: Reviewed warning signs requiring immediate evaluation: sudden severe "thunderclap" headache, headache with fever and neck stiffness, headache with neurological symptoms (weakness, vision loss, confusion), significant change in headache pattern. Patient verbalized understanding and agreed to treatment plan.

---

Example 2: Chronic Migraine, Starting Preventive Therapy

Patient: 41-year-old male
Chief Complaint: Headaches getting worse and more frequent
Visit: Established patient, migraine management

S – Subjective:

Patient followed for migraine, now reports increased frequency and severity over past 4 months. Currently experiencing headaches 10-12 days per month (increased from previous 3-4 days monthly). Characteristics remain consistent with migraine: unilateral throbbing, 6-8/10 severity, photophobia, phonophobia, nausea. Sumatriptan provides relief but patient using 2-3 times weekly now. Missing 2-3 work days monthly due to headaches. Headache diary reviewed: identifies stress and lack of sleep as triggers. Recently promoted to management position with increased responsibilities and longer hours. Sleep decreased to 5-6 hours nightly. Has tried lifestyle modifications including regular exercise and trigger avoidance but frequency continues increasing. Quality of life significantly impacted—canceled family vacation last month due to severe migraine episode.

O – Objective:

Vital Signs: BP 124/78, HR 68
Neurological Exam: Remains normal, no changes from prior exams. CN II-XII intact, motor 5/5, sensation intact, coordination normal, gait normal, no focal deficits.
MIDAS Score: 42 (Grade IV - severe disability)
Headache Diary Review: 11 headache days documented in past month, sumatriptan used 10 days (approaching medication overuse threshold)

A – Assessment:

Chronic migraine (≥15 headache days per month for greater than 3 months, with ≥8 days meeting migraine criteria). Previously episodic migraine now progressed to chronic pattern. Significant functional disability documented by MIDAS score and work absences. Patient at risk for medication overuse headache with current triptan frequency. Lifestyle factors contributing: inadequate sleep, increased stress. Meets criteria for preventive medication therapy: headache frequency greater than 4 days monthly, significant disability, impaired quality of life.

P – Plan:

Preventive Medication Initiated: Starting propranolol 40mg twice daily for migraine prevention. Explained that preventive medications take 6-8 weeks to show full benefit. Goal is to reduce migraine frequency by at least 50%. Reviewed potential side effects: fatigue, dizziness, may affect exercise tolerance. Contraindicated to stop abruptly. Patient has no asthma or significant cardiac history making beta-blocker appropriate first-line choice.

Abortive Therapy: Continue sumatriptan for acute attacks but limit to 2 days per week maximum to prevent medication overuse headache. If preventive medication reduces frequency as expected, triptan use should naturally decrease.

Lifestyle Interventions: Emphasized importance of sleep hygiene—goal 7-8 hours nightly. Discussed stress management: recommended considering meditation app or counseling given work stress. Regular exercise (which patient already doing) encouraged to continue.

Monitoring: Patient to continue headache diary tracking frequency, severity, triggers, medication use. This allows objective assessment of preventive medication efficacy.

Follow-up: Return in 8 weeks to assess response to propranolol. May need dose titration up to 80mg twice daily if inadequate response and tolerating current dose well. Will discuss alternative preventive agents if propranolol ineffective or not tolerated. Discussed that achieving good migraine control may require trying multiple preventive medications before finding optimal regimen.

---

Example 3: Refractory Migraine, Prior Authorization for CGRP Inhibitor

Patient: 38-year-old female
Chief Complaint: Migraines not controlled despite multiple treatments
Visit: Medication management, insurance prior authorization

S – Subjective:

Patient with long-standing chronic migraine history presents for medication management review. Currently experiencing 12-15 migraine days monthly despite preventive therapy. Has systematically tried multiple preventive medications over past 2 years: propranolol (discontinued due to fatigue and exercise intolerance), topiramate (discontinued due to cognitive side effects—"brain fog" interfering with work as accountant), amitriptyline (discontinued due to excessive sedation and weight gain). Currently on no preventive medication after discontinuing amitriptyline 3 months ago. Acute treatment with sumatriptan provides partial relief only. Missing significant work time—used all sick leave last quarter due to migraines. Has been to emergency department twice in past 6 months for intractable migraine requiring IV treatment. Quality of life severely impacted—declined social activities, difficulty maintaining relationships, concerned about job security due to absences. Desperate for more effective treatment.

O – Objective:

Vital Signs: BP 116/72, HR 74
Neurological Exam: Normal comprehensive examination. No focal deficits, normal mental status, cranial nerves intact, motor/sensory intact, coordination normal, gait normal.
Previous Imaging: MRI brain (6 months ago) - normal, no structural abnormalities
MIDAS Score: 58 (Grade IV - severe disability)
Medication Trial Documentation:

• Propranolol 80mg BID x 3 months: minimal benefit, discontinued due to side effects
• Topiramate titrated to 100mg daily x 4 months: no benefit, intolerable cognitive effects
• Amitriptyline 50mg nightly x 3 months: minimal benefit, discontinued due to sedation

A – Assessment:

Chronic migraine, refractory to multiple preventive therapies. Failed adequate trials of three different classes of preventive medications: beta-blocker (propranolol), antiepileptic (topiramate), and tricyclic antidepressant (amitriptyline). Each trial was adequate duration (minimum 8-12 weeks) at therapeutic doses. Severe functional disability with significant impact on employment and quality of life. Multiple emergency department visits indicating inadequate outpatient management with current regimen. Patient is appropriate candidate for CGRP inhibitor therapy based on: 1) chronic migraine diagnosis, 2) failed multiple first-line preventive medications, 3) severe disability with functional impairment, 4) documented inability to tolerate side effects of standard preventives. Normal neuroimaging rules out secondary causes.

P – Plan:

CGRP Inhibitor Therapy: Prescribing erenumab (Aimovig) 70mg subcutaneous injection monthly for migraine prevention. This represents next appropriate step after failure of multiple oral preventive agents. CGRP inhibitors offer different mechanism of action targeting migraine-specific pathway. Generally well-tolerated with side effect profile better than many traditional preventives. Demonstrated efficacy in patients who failed multiple other preventives.

Prior Authorization Documentation: Submitting prior authorization with comprehensive documentation including: chronic migraine diagnosis (12-15 headache days monthly), failed trials of three different preventive medication classes with specific drugs/doses/durations/discontinuation reasons, documented severe functional disability (MIDAS score 58, work absences, ED visits), normal neurological examination, normal brain MRI ruling out secondary causes. Medical necessity clearly established.

Bridging Plan: Given no current preventive medication and 2-4 week prior authorization timeline, prescribed short course of prednisone taper (60mg x 3 days, 40mg x 3 days, 20mg x 3 days) to break current severe migraine cycle. Patient to continue sumatriptan for acute attacks, limit to 2 days weekly.

Patient Education: Reviewed self-injection technique for erenumab (if approved). Explained realistic expectations: may see benefit within first month but full effect often by 3 months. Side effects typically minimal: constipation most common, injection site reactions. Will need 3-month trial to adequately assess efficacy.

Follow-up: Patient to call once prior authorization decision received. If approved, schedule visit for first injection training and documentation. If denied, will appeal with additional supporting documentation and consider neurology referral. Return visit in 4 weeks regardless to check in on current status. Patient provided with neurology referral as backup option if insurance barriers prevent access to needed preventive treatment.

---

Documentation Elements That Make Prior Authorizations Succeed

After helping providers with hundreds of migraine prior authorizations, these documentation elements consistently make the difference between approval and denial:

Frequency documentation must be crystal clear. Not "frequent headaches" but "12-15 headache days per month over past 3 months." Specific numbers that clearly establish chronic vs episodic classification.

ICHD-3 diagnostic criteria should be documented explicitly, at least for the initial diagnosis. This leaves no doubt that you've made an appropriate migraine diagnosis rather than treating non-specific headaches.

Failed medication trials need specific details: medication name, dose reached, duration of trial, and reason for discontinuation (lack of efficacy vs side effects). "Patient tried propranolol in the past without benefit" doesn't cut it for prior authorization.

Functional impact must be quantified. Actual number of work days missed, specific activities patient can't perform, ED visits for migraine. MIDAS scores provide objective disability measurement.

Neurological examination results should be documented completely, even when normal. This shows you've appropriately evaluated for concerning features.

Red flags must be addressed in the documentation. When you've appropriately ruled out dangerous causes, state this explicitly rather than assuming reviewers will understand your clinical reasoning.

For expensive medications, document why cheaper alternatives won't work for this specific patient. Generic triptans failed? Document it. Can't take beta-blockers due to asthma? Document it.

Common Documentation Mistakes That Cause Denials

I've reviewed countless denied prior authorizations for migraine medications. Here are the patterns that consistently cause problems:

Vague frequency descriptions: "Frequent migraines" or "several headaches per month" don't establish chronic vs episodic classification. Insurance needs specific headache days per month.

Missing failed medication trials: Requesting CGRP inhibitor without documenting adequate trials of at least 2-3 first-line preventives guarantees denial.

Inadequate trial documentation: "Patient tried topiramate" without noting dose, duration, or failure reason won't satisfy requirements. Need: "topiramate titrated to 100mg daily over 6 weeks, continued for 12 weeks total, discontinued due to cognitive impairment interfering with work."

No functional impact documentation: Insurance doesn't approve expensive medications just because headaches are painful. They need evidence of disability and impaired function.

Requesting imaging without indication: MRI for straightforward migraine with normal exam usually gets denied without documented red flag features.

Copy-paste notes: If your chronic migraine note is identical to the last three visits, reviewers question whether the patient actually has chronic migraine or whether you're just not documenting properly.

Building an Approvable Prior Authorization Record

Smart migraine documentation starts at the first visit, not when you're ready to prescribe an expensive medication.

From the initial diagnosis, document migraine characteristics using ICHD criteria. This establishes diagnostic credibility.

At each follow-up, document specific headache frequency that month. This creates a longitudinal record proving chronic migraine diagnosis.

When starting preventive medications, document the specific drug, target dose, expected timeline for benefit (usually 6-8 weeks), and plan for assessing effectiveness.

When discontinuing preventive medications, document the specific reason: lack of efficacy after adequate trial (specify duration) or intolerable side effects (specify which ones and impact on patient).

Throughout treatment, document functional impact: work absences, activity limitations, quality of life impairment. MIDAS scores provide objective measurement.

By the time you're ready to request a CGRP inhibitor or referral to neurology, you have a documented story showing: confirmed migraine diagnosis, chronic pattern established over time, systematic trials of appropriate preventive medications, documented functional disability despite treatment attempts.

This documentation framework makes prior authorizations straightforward rather than battles.

How to Document Migraine Characteristics Properly

The International Headache Society's ICHD-3 criteria provide the diagnostic framework. Your documentation should reflect these elements:

For migraine without aura, document at least two of these characteristics: unilateral location, pulsating quality, moderate-to-severe intensity, aggravation by routine physical activity.

Plus document at least one of: nausea/vomiting, photophobia and phonophobia.

Duration: 4-72 hours when untreated or unsuccessfully treated.

Don't just write "patient has migraine headaches." Describe: "Patient reports unilateral throbbing headaches, moderate to severe intensity (7/10), lasting 8-12 hours, aggravated by physical activity, associated with nausea and sensitivity to light and sound."

This documentation makes the diagnosis defensible and gives insurance reviewers confidence that you've made an appropriate diagnosis rather than treating non-specific headaches with expensive migraine medications.

When Documentation Supports Imaging Decisions

Not every migraine patient needs an MRI, but some do. Your documentation should show appropriate decision-making.

Document red flag features when present: new headache after age 50, sudden severe "thunderclap" onset, progressive worsening, neurological symptoms, papilledema, systemic symptoms like fever or weight loss.

When red flags are present, document them clearly and explain why imaging is indicated.

When red flags are absent but you're ordering imaging anyway (patient anxiety, atypical features, refractory to treatment), document your clinical reasoning.

When not ordering imaging despite patient request, document why: typical migraine presentation, normal neurological exam, no concerning features, appropriate to treat empirically.

Good documentation supports whatever clinical decision you make—whether that's ordering imaging or appropriately not ordering it.

Final Thoughts

Migraine documentation requires more strategy than most other conditions because so much depends on it—prior authorizations, imaging approvals, specialist referrals, even disability claims.

The clinical care is often straightforward: diagnose migraine, try preventive medications systematically, escalate when needed.

But the documentation needs to tell a complete story that justifies each step in the treatment progression.

Start with clear diagnostic documentation using ICHD criteria. Track frequency precisely. Document functional impact quantitatively. Record medication trials with specific details about dosing, duration, and outcomes.

By the time you need prior authorization for an expensive treatment, the documentation trail should make approval obvious rather than requiring lengthy appeals.

Whether you document manually or use SOAP Notes Doctor, the goal is the same: capture the clinical reality in a format that supports the care your patients need.

---

Ready to master migraine documentation?
Visit soapnotes.doctor and generate prior-authorization-ready migraine notes in minutes.